Overview

A Randomized, Open-label, Single-dose, Single-center, Crossover Study in Healthy Subjects to Assess the Relative Bioavailability of PT010

Status:
Completed
Trial end date:
2017-12-15
Target enrollment:
Participant gender:
Summary
Randomized, Open-label, Single-dose, Single-center, Crossover Study in Healthy Subjects to Assess the Relative Bioavailability of PT010
Phase:
Phase 1
Details
Lead Sponsor:
Pearl Therapeutics, Inc.
Treatments:
Charcoal